AC Immune reports interim results from Phase 2 trial of ACI-7104.056

Published on 16 Nov 2024 on TipRanks · via Yahoo Finance

AC Immune (ACIU) announced positive interim safety and immunogenicity data from the Phase 2 VacSYn...

Read the rest of the article

Start tracking your investments with Statfolio

AC Immune (ACIU) announced positive interim safety and immunogenicity data from the Phase 2 VacSY...

TipRanks · via Yahoo Finance 16 Nov 2024

AC Immune SA (NASDAQ:ACIU) is set to release its Q3 2024 earnings on Oct 24, 2024. The consensus...

GuruFocus.com · via Yahoo Finance 23 Oct 2024

Key Insights AC Immune to hold its Annual General Meeting on 20th of JuneSalary of CHF578.0k is p...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

AC Immune SA (NASDAQ:ACIU) is possibly approaching a major achievement in its business, so we wou...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

Key Insights The considerable ownership by private equity firms in AC Immune indicates that they ...

Simply Wall St. via Yahoo Finance 24 May 2024

AC Immune SA (NASDAQ:ACIU) shareholders should be happy to see the share price up 17% in the last...

Simply Wall St. via Yahoo Finance 15 Mar 2024

Wall Street had a disappointing start to 2024 as the nine-week winning streak snapped, erasing so...

Zacks via Yahoo Finance 11 Jan 2024

Key Insights Significant control over AC Immune by private equity firms implies that the general ...

Simply Wall St. via Yahoo Finance 13 Dec 2023

AC Immune SA ACIU is making rapid progress in the development of its lead pipeline candidate, ACI...

Zacks via Yahoo Finance 5 Dec 2023

We think intelligent long term investing is the way to go. But no-one is immune from buying too h...

Simply Wall St. via Yahoo Finance 6 Oct 2023